D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.25 MYR -0.79% Market Closed
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Duopharma Biotech Bhd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Free Cash Flow
myr64.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
14%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Free Cash Flow
-myr2.8m
CAGR 3-Years
3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Apex Healthcare Bhd
KLSE:AHEALTH
Free Cash Flow
-myr33.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Free Cash Flow
myr24.9m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Free Cash Flow
myr35.2m
CAGR 3-Years
25%
CAGR 5-Years
11%
CAGR 10-Years
14%
K
Kotra Industries Bhd
KLSE:KOTRA
Free Cash Flow
myr19.7m
CAGR 3-Years
-24%
CAGR 5-Years
-3%
CAGR 10-Years
2%
No Stocks Found

Duopharma Biotech Bhd
Glance View

Market Cap
1.2B MYR
Industry
Pharmaceuticals

Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.

DPHARMA Intrinsic Value
1.69 MYR
Undervaluation 26%
Intrinsic Value
Price
D

See Also

What is Duopharma Biotech Bhd's Free Cash Flow?
Free Cash Flow
64.2m MYR

Based on the financial report for Sep 30, 2024, Duopharma Biotech Bhd's Free Cash Flow amounts to 64.2m MYR.

What is Duopharma Biotech Bhd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
14%

Back to Top